Participate in this on-demand webinar series to learn what’s new in nonalcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD). Leading experts in endocrinology and gastroenterology will discuss hot topics surrounding the diagnosis and treatment of patients with NASH/NAFLD, including:
- Identifying and Managing High-Risk Patients
- NASH Treatment Now and in the Future
- New Strategies for NASH Diagnosis
- Weight Loss and Antidiabetic Drugs
- Real-World Practice Implications
Download slides and audio
Learning objectives
- Evaluate risk and apply appropriate methodology to characterize NAFLD and diagnose NASH in individual patients.
- Apply best practices in the management of patients with NAFLD based on evolving data on lifestyle modification and medical treatment.
- Critically evaluate data on emerging therapies for NASH, including evidence of reversal of fibrosis, risks and benefits, and their potential utility in the treatment of patients with NASH.
- Demonstrate an understanding of clinical trial design and evaluation of endpoints in the setting of NAFLD/NASH.
Program directors and faculty:
Kenneth Cusi, MD, FACP, FACE, Program director
Rita Basu, MD
Juan Pablo Frias, MD, FACE
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Brent A. Neuschwander-Tetri, MD
Philip N. Newsome, PhD, FRCPE
Raymond E. Soccio, MD, PhD
Wing-Kin Syn, MBChB, PhD, FACP, FRCP
Pricing
Member
|
Non-Member
|
Free |
Free |